OPUS GENETICS INC. - COMMON STOCK
1.1800
01-November-24 15:59:56
15 minutes delayed
Stocks
-0.0200
-1.67%
Today's range
1.1600 - 1.2185
ISIN
N/A
Source
NASDAQ
-
16 Mar 2022 07:30:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Oppenheimer Annual Healthcare Conference
10 Mar 2022 09:27:42 By Nasdaq GlobeNewswire
-
08 Mar 2022 08:00:02 By Nasdaq GlobeNewswire
-
08 Feb 2022 08:00:02 By Nasdaq GlobeNewswire
-
31 Jan 2022 06:00:00 By Nasdaq GlobeNewswire
-
Ocuphire to Host Virtual Investor R&D Day on January 31st
25 Jan 2022 07:00:01 By Nasdaq GlobeNewswire
-
05 Jan 2022 07:00:01 By Nasdaq GlobeNewswire
-
08 Dec 2021 08:00:01 By Nasdaq GlobeNewswire
-
23 Nov 2021 09:00:01 By Nasdaq GlobeNewswire
-
Ocuphire Announces Financial Results for the Third Quarter 2021 and Provides Corporate Update
12 Nov 2021 07:00:02 By Nasdaq GlobeNewswire
-
01 Nov 2021 09:30:31 By Nasdaq GlobeNewswire
-
07 Oct 2021 07:00:01 By Nasdaq GlobeNewswire
-
01 Oct 2021 08:49:48 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Presenting at Three Upcoming Healthcare Conferences This Fall
27 Sep 2021 07:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03 Sep 2021 17:00:00 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Presenting at Four Conferences in September
02 Sep 2021 07:00:02 By Nasdaq GlobeNewswire
-
Ocuphire Announces Financial Results for the Second Quarter 2021 and Provides Corporate Update
12 Aug 2021 07:00:01 By Nasdaq GlobeNewswire
-
Ocuphire Pharma Presenting at Two Conferences in August
06 Aug 2021 07:30:00 By Nasdaq GlobeNewswire
-
22 Jul 2021 08:00:02 By Nasdaq GlobeNewswire
-
Ocuphire Selected to Present at Multiple Ophthalmic Conferences in July
13 Jul 2021 09:00:01 By Nasdaq GlobeNewswire